Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received expanded CE mark for its automated insulin delivery (AID) systems. San Diego-based Tandem can now bring its Control-IQ-powered AID systems — the flagship t:slim X2 and miniature Mobi — to European adults with type 2 diabetes and those with type 1 diabetes during pregnancy. Approval in […]
Diabetes
Dexcom to acquire wellness tracking company Nutrisense, launch enhanced Stelo app
Dexcom (Nasdaq:DXCM) announced today that entered into an agreement to acquire Nutrisense and shared plans for upgrades to its Stelo sensor. San Diego-based Dexcom expects its deal to buy Nutrisense for an undisclosed amount in the coming weeks. With the acquisition, the continuous glucose monitor (CGM) maker plans to further expand its ability to support […]
CeQur announces extended wear time, added dosing for mealtime insulin patch pump
CeQur announced today that it picked up two recent FDA clearances for its Simplicity mealtime insulin patch pump system. The FDA cleared Simplicity for an extended wear time of up to seven days and gave the green light to a new 1-unit (1U) device. Additionally, Horw, Switzerland-based CeQur plans to share two clinical posters at […]
PharmaSens enrolls first patient in feasibility study for all-in-one automated insulin patch pump
PharmaSens said today that it enrolled the first patient in a clinical feasibility study of its all-in-one automated insulin patch pump system. The all-in-one pump pairs the Niaa insulin patch pump with a continuous glucose monitor (CGM) made by SiBionics. The companies announced a collaboration aimed at developing the all-in-one solution last year. Their all-in-one wearable […]
Insulet launches enhanced Omnipod 5 algorithm, expands Abbott compatibility
Insulet (Nasdaq:PODD) announced today that it is rolling out new algorithm enhancements for its Omnipod 5 automated insulin delivery system. The company also expanded its compatibility with Abbott sensors, adding the option of pairing Omnipod 5 with FreeStyle Libre 3 Plus. Acton, Massachusetts-based Insulet won FDA clearance for its algorithm enhancements in December 2025. The […]
MiniMed adds Abbott dual glucose-ketone sensor to portfolio, posts Q4 sales beat
MiniMed (Nasdaq:MMED) announced today that it expanded its agreement with Abbott (NYSE:ABT) to add more sensors to its portfolio. The company also announced fourth-quarter earnings results in tandem with the new Abbott integration. MiniMed has an existing partnership with Abbott through a collaboration between the companies agreed in 2024. They integrated Instinct, a sensor made by […]
MyLife integrates MyLoop automated insulin pump with Dexcom G7
MyLife Diabetes Care, CamDiab and Dexcom today announced the integration of the G7 continuous glucose monitor (CGM) into the MyLoop system. MyLoop (previously MyLife Loop), an automated insulin delivery (AID) system, is powered by the CamAPS FX app. The system already integrated with the previous-generation Dexcom G6, as well as Abbott’s FreeStyle Libre 3 Plus. […]
Beta Bionics makes near-real-time, real-world bionic pancreas data publicly available
Beta Bionics (Nasdaq:BBNX) today announced the public availability of near-real-time, real-world iLet Bionic Pancreas data. Irvine, California-based Beta Bionics said its dashboard publishes outcomes for 100% of iLet patients who meet two simple, pre-stated criteria (a provider-reported baseline HbA1c and at least two weeks of data uploaded to the cloud), with no exclusions applied. According […]
MIT, Apollon say needle-free CGM matched accuracy of leading sensors in study
Apollon and an MIT lab today shared clinical findings demonstrating the accuracy of their non-invasive continuous glucose monitor (CGM) device. Boston-based Apollon and MIT’s Laser Biomedical Research Center (LBRC) published their findings from the peer-reviewed clinical study in the Journal of Diabetes Science and Technology. Outcomes demonstrated that a compact, non-invasive CGM device based on band-pass […]
MyLife takes on manufacturing responsibility for insulin pumps
MyLife Diabetes Care today announced its next steps as an independent diabetes care technology company. Burgdorf, Switzerland-based MyLife says it has now become the legal manufacturer for MyLife products, as of today, June 1, 2026. It plans to introduce products under the new legal manufacturer to the market in a step-by-step process beginning July 1, […]
